1.
Product Overview
2.
Research Methodology
3.
Impact of COVID-19 on Doxycycline Market
4.
Executive Summary
5.
Manufacturing Doxycycline
5.1.
Raw Material
5.2.
Machinery
5.3.
Manufacturing Methods
5.4.
Contact Details of Machinery & Raw Material Suppliers
6.
Pharmacodynamic Overview of Doxycycline
6.1.
Mechanism of Action
6.2.
Absorption
6.3.
Volume of Distribution
6.4.
Protein Binding
6.5.
Metabolism
6.6.
Route of Elimination
6.7.
Half-Life
6.8.
Clearance
6.9.
Toxicity
7.
India Doxycycline Market Outlook
7.1.
Market Size & Forecast
7.1.1. By Value &
Volume
7.2.
Market Share & Forecast
7.2.1. By Product Type
(Doxycycline HCL, Doxycycline Hyclate, Doxycycline Calcium, Doxycycline Monohydrate)
7.2.2. By Form (Tablet,
Capsule, Injection, Solution, Syrup, Others)
7.2.3. By Application
(Intestinal Infections, Respiratory Tract Infections, Skin Infections, Genital
Infections, Urinary Tract Infections, Others)
7.2.4. By Route of
Administration (Oral, Intravenous, Others)
7.2.5. By Source (In-house
v/s Contract Manufacturing Organizations)
7.2.6. By Distribution
Channel (Online v/s Offline)
7.2.7. By End User (Adult
v/s Pediatric)
7.2.8. By Region (North,
East, South, West)
7.2.9. By Company
7.3.
Product Market Map
8.
Market Dynamics
8.1.
Drivers/Opportunities
8.2.
Challenges/Restraints
9.
Market Trends & Developments
10.
Policy & Regulatory Landscape
10.1.
Custom Duty & Taxes
10.2.
Government Subsidy & Benefits
10.3.
Relevant Policies & Regulations (GMP, USFDA, WHO Certifications)
11.
Import & Export Analysis
12.
Pricing Analysis
13.
India Economic Profile
14.
Competitive Landscape
14.1.
Company Profiles
14.1.1. Fresenius Kabi India
Pvt. Ltd.
14.1.1.1. Company Brief
14.1.1.2. Production Plants
& Capacity (If Available)
14.1.1.3. Financials (If
Available)
14.1.1.4. Captive Consumption
Vs Merchant Sale
14.1.1.5. Current & Future
Plans
14.1.2. Sun Pharmaceuticals
Industries Ltd.
14.1.3. Ajanta Pharma Ltd.
14.1.4. Lupin Limited
14.1.5. Alembic
Pharmaceuticals Ltd.
14.1.6. Amneal
Pharmaceuticals Pvt. Ltd.
14.1.7. Teva API India
Limited
14.1.8. Emcure
Pharmaceuticals Ltd.
14.1.9. Zydus Cadila Ltd.
14.1.10.
Gland Pharma Ltd.
15.
Strategic Recommendations
16.
About Us & Disclaimer